Onconetix
ONCO
6 hedge funds and large institutions have $1.82M invested in Onconetix in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
32% less capital invested
Capital invested by funds: $2.7M → $1.82M (-$878K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$40.4K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$11.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.7K |
| 4 |
ODG
O'Dell Group
Cincinnati,
Ohio
|
-$130 |
ONCO Hedge Fund Activity: Q3 2023 in Review
6 of the 6,309 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q3 2023, worth a combined $1.82M — down 32% from $2.7M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ONCO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.07M. The largest seller was Susquehanna International Group, cutting an estimated $40.4K.
- 6 institutional investors held Onconetix (ONCO) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $1.82M of Onconetix stock for Q3 2023, down 32% quarter-over-quarter.
- 1 fund opened new Onconetix positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Onconetix buyer in Q3 2023 was Armistice Capital, an estimated $1.07M added.
- The largest Onconetix seller in Q3 2023 was Susquehanna International Group, an estimated $40.4K sold.
Based on aggregated 13F filings for Q3 2023.